Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

IHC Detection of MMR Protein Series Tweets – Detection of MMR/MSI

Introduction:The first article clarified the 'triangular' relationship among CRC, MMR, and MSI. We learned that dMMR is clinically equi...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

New Applications of Antibodies: Research on Galectin-3 in Head and Neck Squamous Cell Carcinoma

Introduction:In head and neck squamous cell carcinoma, approximately 25% are associated with high-risk (HR) human papillomavirus (HPV),...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

The 38th Issue of “Mai Mai” Pathology Weekly Reading Notes | Immunohistochemical Markers for the Diagnosis of Ewing Sarcoma/PNET

Introduction:Ewing sarcoma (ES) or primitive neuroectodermal tumor (PNET) refers to a group of poorly differentiated malignant tumors c...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Immunohistochemical Antibody Selection Scheme for Spleen Diseases (Part 3)

Introduction:In the previous two articles, we introduced the histology of the spleen, flow cytometry, and the application of immunohist...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

One Image to Understand: Consensus on Pathological Diagnosis of Gastrointestinal Adenomas and Benign Epithelial Polyps

Introduction:With the widespread application of fiberoptic endoscopy technology, the detection rate of gastrointestinal polypoid lesion...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Cancer Talk: The “Fortunate” Thyroid Cancer?

Introduction:Since 2000, the incidence of thyroid cancer in Chinahas been increasing at an average annual rate of about 20%has become t...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Napoleon’s Hat: A Unique Diagnostic Clue for Reactive Hyperplastic Alveolar Cells

Introduction:Various types of acute and subacute lung injuries can cause severe reactive hyperplasia of alveolar epithelium and exhibit...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Get Lost, Tumor: EB Virus’s Self-Narrative – The Stomach Cancer Chapter

Introduction:Epstein-Barr virus (EBV), also known as human herpesvirus type IV, is highly prevalent in the population and is closely as...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Beware! The Pure Scattered Punctate Nuclear Staining Pattern of MLH1!

Introduction:In clinical pathology practice, we typically use the following two methods to test pathological specimens from Lynch syndr...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Pathology Diagnosis Pitfalls: Plasmablastic Lymphoma May Express CK

Introduction:The significance of immunohistochemistry in lymphoma diagnosis is undeniable. Many types of lymphoma have unique immunophe...
Continue reading
  • ‹
  • 1
  • 2
  • 3
  • 4
  • 5
  • ›
  • »

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar